Loading Rate of Exogenous and Autoantigenic Determinants on Major Histocompatibility Complex Class II Mediates Resistance to Multiple Sclerosis


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Genetic analysis of thousands of patients with multiple sclerosis (MS) and healthy Russian donors showed that the carriage of groups of HLA-DRB1*15 and HLA-DRB1*03 alleles is associated with the risk of MS, whereas the carriage of groups of HLA-DRB1*01 and HLA-DRB1*11 alleles is protective. Recombinant HLA-DRB1*01:01 with a high affinity can recognize the fragments of myelin basic protein (MBP), one of the autoantigens in MS. However, the comparison of the kinetic parameters of the load of MBP and viral HA peptides on HLA-DRB1*01:01, which is catalyzed by HLA-DM, showed a significantly lower rate of exchange of CLIP for MBP peptides. We assume that the observed protective properties of the group of HLA-DRB1*01 alleles may be directly associated with the ability of HLA-DRB1*01:01 to kinetically distinguish peptides of exogenous and endogenous nature.

Sobre autores

A. Mamedov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Autor responsável pela correspondência
Email: bioaz12@gmail.com
Rússia, Moscow, 117997

M. Zakharova

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation

Email: vera.knorre@gmail.com
Rússia, Moscow, 117997; Moscow, 117997

O. Favorova

Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation

Email: vera.knorre@gmail.com
Rússia, Moscow, 117997

O. Kulakova

Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation

Email: vera.knorre@gmail.com
Rússia, Moscow, 117997

A. Boyko

Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation

Email: vera.knorre@gmail.com
Rússia, Moscow, 117997

V. Knorre

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Autor responsável pela correspondência
Email: vera.knorre@gmail.com
Rússia, Moscow, 117997

N. Vorobieva

Institute of Gene Biology, Russian Academy of Sciences

Email: vera.knorre@gmail.com
Rússia, Moscow, 119334

E. Khurs

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences

Email: vera.knorre@gmail.com
Rússia, Moscow, 119991

I. Kiselev

Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation

Email: vera.knorre@gmail.com
Rússia, Moscow, 117997

N. Baulina

Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation

Email: vera.knorre@gmail.com
Rússia, Moscow, 117997

A. Gabibov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Biological Faculty, Moscow State University

Email: vera.knorre@gmail.com
Rússia, Moscow, 117997; Moscow, 119234

A. Belogurov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Biological Faculty, Moscow State University

Email: vera.knorre@gmail.com
Rússia, Moscow, 117997; Moscow, 119234

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Pleiades Publishing, Inc., 2019